back arrowBack To Resources medical_practice_sales

The Three Clocks That Decide a Dermatology Practice Sale

 The question I hear most often from dermatology practice owners is some version of “Is now the right time to sell?” It sounds like one question, but in my experience, answering it means checking three different clocks.

There’s the market clock, what buyers are doing, where capital is flowing, and how a practice like yours would be received today. There’s the practice clock, whether your practice has everything in place today to ensure a meaningful outcome. Then there’s the ever-convoluted personal clock, whether you’re ready for a sale (financially or emotionally). The owners who capture the strongest outcomes are the ones who check all three clocks regularly and put themselves in position to transact on their terms.

The Market Clock: What Is Buyer Activity Like?

Most owners read the market through headlines and hallway conversations at conferences. Buyers read it through their own pipelines, and the two pictures rarely match.

Buyer appetite in dermatology moves in a methodical manner. New capital enters, platforms refine their acquisition strategies and the practice profiles they’re chasing change with it. At certain points in the cycle, there is more capital pursuing strong practices than there are strong practices to buy causing buyers to move faster, compete harder, and stretch for the right fit. At other points in time, those same buyers may become more selective or pause acquisitions after they’ve met their mandates while they digest what they’ve bought. From the outside, the two environments can look nearly identical. From inside a process, they can produce very different results.

This is where a specialized advisor earns their keep well before an engagement begins. Our team is in the market every week meeting with strategic platforms and groups acquiring dermatology practices, observing which practices they are committing capital to and taking notes regarding the practices they walk away from. Our vantage point allows us to understand who is actively buying, what they’re prioritizing, and determine how your practice would be perceived if it went to market today.

The conversation about which buyers are ideal for your practice honestly shouldn’t start when you’re ready to sell. The owners I’ve worked with who have had uniquely positive outcomes started understanding the buyer landscape several years before they engaged with a buyer. This also shaped how they ran the practice in the meantime and it kept them in a position to move whenever the market window was ideal for their practice.

The Practice Clock: Is Everything in Place for a Meaningful Outcome?

At TUSK, we always advise future clients to run their business as if they are selling tomorrow; this ensures that time is on their side if the day arrives that a strong transaction is needed expeditiously. A meaningful outcome is more than a strong headline number. It’s a valuation that holds up through diligence, terms that protect you, and a structure that delivers what was promised. Buyers aren’t evaluating your practice on revenue or EBITDA alone; they’re trying to determine how durable those earnings will be after close, how much intrinsic risk lies in the patient base and operations, and where they can immediately add value to what’s in place today. The following key areas that I’m expanding on are major predictors of outcomes.

Financials do come first. This is one of the prime areas where an advisor can add value; unrepresented deals have a long history of buyers recasting EBITDA downward in diligence, challenging add-backs, disputing one-time expenses, and re-trading price late in the process when the numbers don’t hold water. Having an advisor work with you to understand how a buyer is going to look at your practice and build rationale into the operations of the business is a meaningful component to having a predictable outcome at the highest end of the valuation range. One of the reasons this is so important is because engaging in a transaction that encompasses a meaningful portion of your life’s work is a very emotionally exhausting process; if we add deteriorating enterprise value to the mix, the deal can be insurmountable. The deals I’ve seen hold their value are the ones where every adjustment was documented and defensible before the practice ever went to market. Clean, normalized financials reduce the noise through closing and ensure your mind is clear when conversations about structure & Asset Purchase Agreement negotiations are taking place.

Revenue mix is a key to mitigating risk in the eyes of a buyer. A healthy blend of medical, surgical, and cosmetic dermatology demonstrates multiple sources of patient demand and room to grow. A meaningful aesthetics component, injectables, lasers, etc., adds a cash-pay stream that isn’t exposed to reimbursement pressure, while surgical depth such as Mohs adds further durability to the earnings base through specialized demand.

Then there’s the headline question buyers probe hardest: how much of this practice is you? If you are currently producing 50% of the practice’s revenue, then our next step is to understand how we can get more providers under you to create redundancy within the business. They want a provider team, physicians, PAs, NPs, that can retain patients, generate revenue, and support growth after the transaction. A diligent buyer will examine provider productivity, tenure, and will develop scenarios around what happens if a key physician leaves. They’ll also look at payor mix and reimbursement rates, new patient trends, patient retention and look for patient procedure concentration amongst providers.

A practice posting strong financial results can still carry weaknesses in the areas described above (and others). Weaknesses can ultimately translate into a lower valuation, heavier deal protection, a longer process and fewer interested buyers. Little of what we’ve touched on can be put into place in the ninety days it takes to bring your practice to the market. Building provider depth, reducing owner dependency, establishing varied revenue streams and healthy patient metrics often takes years. Which is exactly why the practice clock, in my opinion, is the one to start keeping an eye on first.

The Personal Clock: The One That’s Hardest to Read

My wife is a practice owner, so I’ve had this conceptual conversation at the kitchen table, not just across a conference table. What makes the personal clock the hardest of the three to read is that it’s the only clock with two hands, a financial one and an emotional one, and they absolutely move independently. Most owners don’t sit down to try and read it until something forces the question (often a buyer’s unsolicited call or a life event), and reading it under pressure is the worst time to try and understand what it’s reading.

The financial hand is the more objective of the two, and it’s the one a financial advisor can help you read. What do you need out of a sale? Not just the headline number, but how the proceeds actually arrive: cash at close, rollover equity, an earnout, and the terms wrapped around each. Does that outcome fund whatever comes next? Working through those mechanics early puts a real number on “enough,” and knowing that number is what lets you evaluate offers on your terms. This is also a reference point of what a successful outcome looks like for you. Often times we find ourselves having the conversation: Is this deal crossing a finish line for you and your family, or is it a victory lap? As a transaction advisor, knowing this is paramount in understanding where the risks lie and we can better inform clients on what risks can and shouldn’t be taken.

The emotional hand is the one no advisor can read for you, and I’ve watched owners misread it in both directions. Some wait until they’re fully burned out, then feel pressure to take the first serious offer in front of them (and best offer will often have a 5-year employment agreement attached to it). Others have a prepared practice, a favorable market, and real interest from buyers, and keep waiting on the hope that next year’s valuation will be better, but not understand why they are contemplating a sale outside of the numbers. Neither position is where you want to negotiate from. Being ready emotionally also means knowing what you want your role to be afterward, staying on for years after your required employment agreement, transitioning out over time, or leaving as soon as your contract has matured. If the latter, this can create a time pressure on transacting as soon as possible to ‘get the clock started’ and that is not a position of strength.

Reading All Three Together

There’s no mathematical formula that names the perfect moment to sell a dermatology practice, and waiting for every variable to line up is its own mistake. This is as much art as it is science. The point is to check all three clocks regularly, on your terms, well before you intend to transact, and each one is read differently. The practice clock moves the slowest, which is why it’s the one to start watching first. The market clock is best read by someone who is in the market every week. And the personal clock, hard as it is to read, gets easier to read with practice and methodical checkpoints.

Is the market creating a real opportunity for your practice? Is everything in place for a meaningful outcome? And are you ready, financially and emotionally, for what comes with a transaction? Owners who keep current answers to those questions give themselves time to strengthen the practice, understand the buyers, and get clear on what they actually want outside of the numbers. When the three clocks finally align, they aren’t reacting to an opportunity; they’ve arrived at a moment in time that you have pre-determined is the right moment, on your terms.

Know Where You Stand

TUSK Practice Sales has closed 200+ transactions and $1.5B+ in deal value, 100% of it on the sell side. We never represent buyers. For owners who want help reading their clocks, TUSK offers a complimentary TUSKVal analysis: a candid assessment of where your practice stands today, how buyers would view it, and what the path forward could look like. No commitment. No sales pressure.

To schedule a confidential conversation, reach out at [email protected] or visit www.TuskPracticeSales.com.

Frequently Asked Questions

Do I need to start preparing my practice even if I'm not ready to sell yet?

Yes. The strongest outcomes come from owners who understand the buyer landscape and run their practice as if selling is always on the table, years before they actually engage with a buyer. Financials, provider depth, and revenue mix take years to build and can’t be manufactured in the ninety days it takes to bring a practice to market.

What should I do first if I'm just starting to think about selling?

Start with a conversation, not a decision. Talk to an advisor early, even years before you plan to sell, so you understand what buyers are looking for and where your practice stands today. From there, focus on the fundamentals: clean up your financials, diversify your revenue where you can, and build out your provider team so the practice isn’t overly dependent on you. Getting a baseline valuation, like a TUSKVal, is also a low-pressure way to see where you stand without committing to anything.

How do I find out what my practice might be worth today?

TUSK offers a complimentary TUSKVal analysis, a candid look at where your practice stands today, how buyers would view it, and what your path forward could look like. No commitment, no sales pressure.

Alex Cherniavsky, Managing Director and Partner at TUSK Practice Sales

About the author

Alex Cherniavsky

Managing Director & Partner, TUSK Practice Sales

Alex Cherniavsky is a Managing Director and Partner at TUSK Practice Sales. He works with healthcare practice owners to build a clear, defensible picture of what their business is worth, giving them the confidence to make informed decisions about their future. He came to healthcare M&A from institutional finance, having valued over $750M in transactions at Wendy's Corporation and co-developed valuation models supporting a $10B re-franchise sale at Galt & Company. That background means TUSK's clients receive the same analytical rigor that Fortune 500 companies rely on. Alex is also co-owner of a dental practice in North Carolina alongside his wife, and holds a BBA from the University of Florida. At TUSK, he is part of a team that has closed over $1.5B across 200+ healthcare transactions.